Designed as sutures, delivered as tacks
Superior fixation strength from the closed locked loop suture concept1
Revolutionary light-weight design significantly minimizes implanted foreign body material2
Low profile, minimal surface area exposed to viscera5
More implanted material increases foreign body reaction, which may increase pain.6,7
As hernia meshes become lighter, the implanted foreign body mass associated with the fixation means becomes greater.
Tacks may contribute more than half the total implanted foreign body material.2
Fixation Without the Bulk
FasTouch presents a reloadable, cartridge-based system that delivers up to 25 tacks per cartridge. Instead of opening a new device, dramatically increasing the cost of the procedure, the FasTouch system reloadable cartridge platform enables surgeons to open just a new cartridge.
Via Surgical plans to provide surgeons with a variety of cartridge offerings to meet a various clinical applications and surgeon preferences and potentially reduce OR costs8 when more than 25 tacks are needed in a single procedure.
Via Surgical Ltd. provides next-generation fixation for hernia repair. Realizing that many hernia repairs make use of multiple means for mesh fixation — anchor/helical hernia tacks, manually applied transfascial sutures — Via Surgical has developed its FasTouch™ system to provide deployable transfascial suture fixation that is strong and consistent, yet easily and rapidly deployed.
FasTouch, with its lightweight deployable sutures, provides a comprehensive fixation solution for hernia repair. The fixation strength of the sutures stems from the closed locked-loop suture concept. The minimal amount of material in the sutures may reduce foreign body response and chronic pain.
Via Surgical was founded in 2012 by Lena and Ofek Levin and Arik Levy, an experienced team that is dedicated to improving and enhancing hernia repair. This same team previously founded and led PolyTouch Medical, developers of an advanced mesh-positioning device for greater accuracy and shorter procedure time.
Ofek Levin, Co-founder & CEO, MBA
Mr. Levin served as Co-founder & CEO of PolyTouch Medical Ltd. (acquired in 2011). He has nearly 10 years of experience managing medical device companies and has completed numerous capital raising ,filed more than dozens patents, (8 issued patents) and led an M&A transaction with a multi-billion international medical device company. Prior to that he served as a circuit analog engineer at Tower Semiconductor and SCD (Rafael). He received an MBA from Technion – Israel Institute of Technology and a B.Sc in Electrical and Electronics Engineering from Tel-Aviv University. Mr. Levin won the first place at Biztec07, Israel National Entrepreneurship Competition together with Arik Levy and Lena Levin.
Arik Levy, Co-founder & CTO, M.Sc
Prior to Via Surgical, Mr. Levy served as co-founder & CTO of PolyTouch Medical (acquired in 2011). Mr. Levy has more than 15 years of R&D experience including in academic medical research, Intel and IDF. He filed more than dozen of patent applications, (8 issued patents). Mr. Levy won the first place at Biztec07, Israel National Entrepreneurship Competition together with Ofek Levin and Lena Levin. Mr. Levy received an MSc and a BSc in Biomedical Engineering (cum laude) from Tel-Aviv University.
Lena Levin, CPA, Co-founder & CFO, MBA
Ms. Levin served as co-founder & CFO of PolyTouch Medical (acquired in 2011). She has more than 10 years of experience in financial and accounting management of growth-oriented medical device companies, has completed numerous capital raising from private investors and OCS and completed an M&A transaction with a multi-billion international medical device company. Prior to that, she served as a corporate analyst at Corporate Finance Dep. and as an associate at the Professional Dep. at BDO Ziv Haft Accounting firm. Ms. Levin won the first place at Biztec07, Israel National Entrepreneurship Competition. She received an MBA from Technion – Israel Institute of Technology, a BA in Accounting (magna cum laude) from Tel-Aviv University and a BA in English Language and Literature & Sociology and Anthropology (magna cum laude) from Haifa University.
John Gomes, Chief Commercial Officer
Mr. Gomes is a senior executive with successful global experience in the Medical Industry. He has held advancing positions from Large, fortune 50 to early stage companies, amongst them Johnson & Johnson, Inc and Atrium Medical Corporation. He comes to us from Gomes Medical Services Group, LLC. as Founder and Principal. His areas of concentration and success have been in sales, development, commercialization, marketing, and strategy. Results driven, he has worked with early stage companies developing novel technologies to established organizations expanding their portfolio, brand, markets, and leadership. John is a graduate of Babson College.
Strategic & Medical Advisory Board
Stephen Blumenreich, Corporate Board Advisor and BOD Observer
Managing Director at Healthcare Investment Banking SunTrust Robinson Humphrey.
Over 20 years of experience advising growth-oriented medical device companies. Completed numerous capital raising and M&A transactions in the healthcare sector. MBA from the Wharton School of the University of Pennsylvania and an AB from Dartmouth College.
Karl A. LeBlanc, MD, MBA, FACS
Managing Partner of the Surgeons Group, Baton Rouge. Clinical Professor of Surgery, Louisiana State University School of Medicine. Past president of the American Hernia Society.
David B. Earle, MD, FACS
Director, Minimally Invasive Surgery, Baystate Medical Center Associate Professor of Surgery, Tufts University School of Medicine. Chairman at SAGES Guidelines Committee.
Brian P. Jacob MD, FACS
Partner at the Laparoscopic Surgical Center of New York and Associate Clinical Professor of Surgery, The Icahn School of Medicine at Mount Sinai, New York City.
Founder of International Hernia Collaboration, Regional Medical Director, NY – AngelMD.
David C. Chen, MD, FACS
Associate Professor of Clinical Surgery UCLA Medical Center, Santa Monica Associate Director of Surgical Education Clinical Director, Lichtenstein Amid Hernia Clinic at UCLA.
1. BT-012 bench test comparing sheer force strength between FasTouch and various available fixation devices; porcine model, fresh extracted porcine abdominal muscle wall, comparison per adjacent locations.
2. BT-031 bench test comparing weights of the FasTouch fastener various other available fixation fasteners.
3. Covidien Inc. study comparing reloadable cartridge-based fixation device vs. non-reloadable fixation device in terms of cost savings. ReliaTack™ overview.
4. Surgeon testimonials AHS2013 & AHS2014 surveys. March 2015.
5. BT-032 bench test comparing FasTouch fastener’s surface area facing the bowel in relation to various other available fixation fasteners.
6. C. Frangou. 2012. Too many tacks associated with postoperative hernia pain. General Surgery News.
7. B. Klosterhalfen. 2005. The lightweight and large porous mesh concept for hernia repair.Expert Rev Med DevicesJan;2(1):103-17 (doi:10.1586/174344126.96.36.199.
8. When 26-50 tacks are needed.